Answers are grounded in this paper and cite their sources.
Recent studies on the mechanism of action of rifampicin have shown that the drug inhibits the initiation of transcription by interacting with RNA polymerase without preventing the completion of RNA chains in the process of being synthesized (see Mosteller and Yanofsky, 1970, for a survey of the relevant literature). A technique has been developed to use the properties of this drug to study the distribution of polymerase molecules in bacterial cells and related problems concerning RNA synthesis.
No takes yet. Share an insight, caveat, or question.
Pato et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: